Indian benchmarks indices ended lower on Wednesday, as advances in heavyweight financials and oil and gas firms were offset by losses in consumer stocks. Investors stayed cautious ahead of the Reserve Bank of India’s three-day monetary policy meeting, which commenced today, with expectations of an impending rate cut.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.